LONDON--(BUSINESS WIRE)--The prevalence of cardiac arrhythmias has increased significantly in recent years, owing to the increased risk of stroke and hospitalizations. This is encouraging various ...

Austin, United States, June 15, 2026 (GLOBE NEWSWIRE) -- "According to SNS Insider, the Cardiac Mapping Systems Market was valued at USD 4.09 billion in 2025 and is projected to reach USD 8.95 billion ...

Pune, India, Aug. 11, 2021 (GLOBE NEWSWIRE) -- The rise in geriatric population and their susceptibility towards various health issues such as cardiac problems are driving the global cardiac mapping ...

For patients with heart rhythm disorders, such as atrial fibrillation, cardiac ablations can eliminate the problem at the source. These common procedures use heat or cold to destroy the cells ...

Read the 120-page report with TOC on “3D Cardiac Mapping Systems Market Analysis Report by Product (Contact 3D cardiac mapping systems and Non-contact 3D cardiac mapping systems), Geography (Asia, ...

Boston Scientific's 3-D navigation system for cardiac mapping has received 510(k) clearance from the FDA. The Rhythmia Mapping system aims to make electrophysiology procedures and catheter ablations ...

Corify Care's proprietary Global Volumetric Mapping technology, described in Communications Medicine, represents a new approach to cardiac electrophysiology. The publication marks the first system ...

3D cardiac mapping is a cutting-edge technology used in the diagnosis and treatment of heart rhythm disorders. It allows for the precise localization of arrhythmias and aids in guiding catheter ...

- EnSite™ X EP System with EnSite Omnipolar Technology (OT) provides a 360-degree view of the heart, regardless of catheter orientation, for cardiac mapping without compromise ABBOTT PARK, Ill., Jan.

Cardiac mapping is an essential diagnostic tool. These imagining tools are used for diagnosing arrhythmias in the heart. Cardiac mapping can be done in several ways. These techniques may be applied to ...

A Johnson & Johnson subsidiary was hit with a suit in the Central District of California, claiming it’s leveraging its cardiac mapping technology monopoly to prevent “reprocessing” of the single-use ...